搜索结果1-10 的 9339 / Two-phase

  1. 神经科- 临床试验- 妙佑医疗国际

    ... Phase 2 Dose (RP2D) of NMS-03305293 in combination with temozolomide (TMZ) in patients with diffuse gliomas at first relapse (Phase I), and to determine the ...

  2. 神经科- 临床试验- 妙佑医疗国际

    ... Phase 2 Dose (RP2D) of NMS-03305293 in combination with temozolomide (TMZ) in patients with diffuse gliomas at first relapse (Phase I), and to determine the ...

  3. 神经科- 临床试验- 妙佑医疗国际

    ... Phase 2 Dose (RP2D) of NMS-03305293 in combination with temozolomide (TMZ) in patients with diffuse gliomas at first relapse (Phase I), and to determine the ...

  4. 神经科- 临床试验- 妙佑医疗国际

    ... Phase 2 Dose (RP2D) of NMS-03305293 in combination with temozolomide (TMZ) in patients with diffuse gliomas at first relapse (Phase I), and to determine the ...

  5. 神经科- 临床试验- 妙佑医疗国际

    ... Phase 2 Dose (RP2D) of NMS-03305293 in combination with temozolomide (TMZ) in patients with diffuse gliomas at first relapse (Phase I), and to determine the ...

  6. 神经科- 临床试验- 妙佑医疗国际

    ... Phase 2 Dose (RP2D) of NMS-03305293 in combination with temozolomide (TMZ) in patients with diffuse gliomas at first relapse (Phase I), and to determine the ...

  7. 神经科- 临床试验- 妙佑医疗国际

    ... Phase 2 Dose (RP2D) of NMS-03305293 in combination with temozolomide (TMZ) in patients with diffuse gliomas at first relapse (Phase I), and to determine the ...

  8. 神经科- 临床试验- 妙佑医疗国际

    ... Phase 2 Dose (RP2D) of NMS-03305293 in combination with temozolomide (TMZ) in patients with diffuse gliomas at first relapse (Phase I), and to determine the ...

  9. 神经科- 临床试验- 妙佑医疗国际

    ... Phase 2 Dose (RP2D) of NMS-03305293 in combination with temozolomide (TMZ) in patients with diffuse gliomas at first relapse (Phase I), and to determine the ...

  10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of the study. ... The study will be performed in two phases: Phase I will be ...